Advertisement

Fecal Microbiota Transplantation

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Gastroenterology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zhang F.
        • Luo W.
        • Shi Y.
        • et al.
        Should we standardize the 1,700-year-old fecal microbiota transplantation?.
        Am J Gastroenterol. 2012; 107 ([author reply: 1755–6]): 1755
        • Brandt L.J.
        • Aroniadis O.C.
        • Mellow M.
        • et al.
        Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
        Am J Gastroenterol. 2012; 107: 1079-1087
        • Borody T.J.
        • Warren E.F.
        • Leis S.M.
        • et al.
        Bacteriotherapy using fecal flora: toying with human motions.
        J Clin Gastroenterol. 2004; 38: 475-483
        • Eiseman B.
        • Silen W.
        • Bascom G.S.
        • et al.
        Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.
        Surgery. 1958; 44: 854-859
        • Vindigni S.M.
        • Broussard E.K.
        • Surawicz C.M.
        Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.
        Expert Rev Gastroenterol Hepatol. 2013; 7: 615-628
        • Hamilton M.J.
        • Weingarden A.R.
        • Unno T.
        • et al.
        High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.
        Gut Microbes. 2013; 4: 125-135
        • Khoruts A.
        • Dicksved J.
        • Jansson J.K.
        • et al.
        Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.
        J Clin Gastroenterol. 2010; 44: 354-360
        • Gough E.
        • Shaikh H.
        • Manges A.R.
        Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.
        Clin Infect Dis. 2011; 53: 994-1002
        • Kassam Z.
        • Lee C.H.
        • Yuan Y.
        • et al.
        Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.
        Am J Gastroenterol. 2013; 108: 500-508
        • Food and Drug Administration Center for Biologics Evaluation and Research
        Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies.
        Food and Drug Administration, Silver Spring (MD)2013
        • Choi H.H.
        • Cho Y.S.
        Fecal microbiota transplantation: current applications, effectiveness, and future perspectives.
        Clin Endosc. 2016; 49: 257-265
        • Brandt L.J.
        • Aroniadis O.C.
        An overview of fecal microbiota transplantation: techniques, indications, and outcomes.
        Gastrointest Endosc. 2013; 78: 240-249
        • OpenBiome
        OpenBiome FMT capsule G3 clinical primer.
        OpenBiome, Medford (MA)2016
        • Youngster I.
        • Russell G.H.
        • Pindar C.
        • et al.
        Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
        JAMA. 2014; 312: 1772-1778
        • Lessa F.C.
        • Gould C.V.
        • McDonald L.C.
        Current status of Clostridium difficile infection epidemiology.
        Clin Infect Dis. 2012; 55: S65-S70
        • Lessa F.C.
        Community-associated Clostridium difficile infection: how real is it?.
        Anaerobe. 2013; 24: 121-123
        • Khanna S.
        • Pardi D.S.
        The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
        Expert Rev Gastroenterol Hepatol. 2010; 4: 409-416
        • McFarland L.V.
        • Surawicz C.M.
        • Rubin M.
        • et al.
        Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
        Infect Control Hosp Epidemiol. 1999; 20: 43-50
        • van Nood E.
        • Vrieze A.
        • Nieuwdorp M.
        • et al.
        Duodenal infusion of donor feces for recurrent Clostridium difficile.
        N Engl J Med. 2013; 368: 407-415
        • Cammarota G.
        • Masucci L.
        • Ianiro G.
        • et al.
        Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.
        Aliment Pharmacol Ther. 2015; 41: 835-843
        • Kelly C.R.
        • Khoruts A.
        • Staley C.
        • et al.
        Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
        Ann Intern Med. 2016; ([Epub ahead of print])
        • Surawicz C.M.
        • Brandt L.J.
        • Binion D.G.
        • et al.
        Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.
        Am J Gastroenterol. 2013; 108 ([quiz: 499]): 478-498
        • Debast S.B.
        • Bauer M.P.
        • Kuijper E.J.
        • et al.
        European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
        Clin Microbiol Infect. 2014; 20: 1-26
        • Youngster I.
        • Sauk J.
        • Pindar C.
        • et al.
        Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.
        Clin Infect Dis. 2014; 58: 1515-1522
        • Konijeti G.G.
        • Sauk J.
        • Shrime M.G.
        • et al.
        Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.
        Clin Infect Dis. 2014; 58: 1507-1514
        • Ott S.J.
        • Musfeldt M.
        • Wenderoth D.F.
        • et al.
        Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
        Gut. 2004; 53: 685-693
        • Frank D.N.
        • St Amand A.L.
        • Feldman R.A.
        • et al.
        Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.
        Proc Natl Acad Sci U S A. 2007; 104: 13780-13785
        • Fujimoto T.
        • Imaeda H.
        • Takahashi K.
        • et al.
        Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
        J Gastroenterol Hepatol. 2013; 28: 613-619
        • Sokol H.
        • Pigneur B.
        • Watterlot L.
        • et al.
        Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
        Proc Natl Acad Sci U S A. 2008; 105: 16731-16736
        • Damman C.J.
        • Miller S.I.
        • Surawicz C.M.
        • et al.
        The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?.
        Am J Gastroenterol. 2012; 107: 1452-1459
        • Bennet J.D.
        • Brinkman M.
        Treatment of ulcerative colitis by implantation of normal colonic flora.
        Lancet. 1989; 1: 164
        • Borody T.J.
        • George L.
        • Andrews P.
        • et al.
        Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?.
        Med J Aust. 1989; 150: 604
        • Borody T.J.
        • Warren E.F.
        • Leis S.
        • et al.
        Treatment of ulcerative colitis using fecal bacteriotherapy.
        J Clin Gastroenterol. 2003; 37: 42-47
        • Colman R.J.
        • Rubin D.T.
        Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
        J Crohns Colitis. 2014; 8: 1569-1581
        • Anderson J.L.
        • Edney R.J.
        • Whelan K.
        Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease.
        Aliment Pharmacol Ther. 2012; 36: 503-516
        • Vindigni S.M.
        • Zisman T.L.
        • Suskind D.L.
        • et al.
        The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.
        Therap Adv Gastroenterol. 2016; 9: 606-625
        • Kassinen A.
        • Krogius-Kurikka L.
        • Makivuokko H.
        • et al.
        The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
        Gastroenterology. 2007; 133: 24-33
        • Simren M.
        • Barbara G.
        • Flint H.J.
        • et al.
        Intestinal microbiota in functional bowel disorders: a Rome foundation report.
        Gut. 2013; 62: 159-176
        • Pinn D.M.
        • Aroniadis O.C.
        • Brandt L.J.
        Is fecal microbiota transplantation the answer for irritable bowel syndrome? A single-center experience.
        Am J Gastroenterol. 2014; 109: 1831-1832
        • Pinn D.M.
        • Aroniadis O.C.
        • Brandt L.J.
        Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?.
        Neurogastroenterol Motil. 2015; 27: 19-29
        • Nicholson J.K.
        • Holmes E.
        • Kinross J.
        • et al.
        Host-gut microbiota metabolic interactions.
        Science. 2012; 336: 1262-1267
        • Ley R.E.
        • Turnbaugh P.J.
        • Klein S.
        • et al.
        Microbial ecology: human gut microbes associated with obesity.
        Nature. 2006; 444: 1022-1023
        • Turnbaugh P.J.
        • Ley R.E.
        • Mahowald M.A.
        • et al.
        An obesity-associated gut microbiome with increased capacity for energy harvest.
        Nature. 2006; 444: 1027-1031
        • Vrieze A.
        • Van Nood E.
        • Holleman F.
        • et al.
        Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.
        Gastroenterology. 2012; 143: 913-916.e7
        • Ananthaswamy A.
        Faecal transplant eases symptoms of Parkinson's.
        New Sci. 2011; 209: 01
        • Borody T.
        • Leis S.
        • Campbell J.
        • et al.
        Fecal microbiota transplantation (FMT) in multiple sclerosis (MS).
        Am J Gastroenterol. 2011; 106: S352
        • Borody T.
        • Campbell J.
        • Torres M.
        • et al.
        Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT].
        Am J Gastroenterol. 2011; 106: S352
        • Finegold S.M.
        • Molitoris D.
        • Song Y.
        • et al.
        Gastrointestinal microflora studies in late-onset autism.
        Clin Infect Dis. 2002; 35: S6-S16
        • Kelly C.R.
        • Ihunnah C.
        • Fischer M.
        • et al.
        Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
        Am J Gastroenterol. 2014; 109: 1065-1071
        • Agrawal M.
        • Aroniadis O.C.
        • Brandt L.J.
        • et al.
        The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals.
        J Clin Gastroenterol. 2016; 50: 403-407
        • Vindigni S.M.
        • Surawicz C.M.
        Stool transplant for the senior citizen: is it safe?.
        Maturitas. 2016; 88: 23-24
        • Kelly C.R.
        • Kahn S.
        • Kashyap P.
        • et al.
        Update on Fecal Microbiota Transplantation 2015: indications, methodologies, mechanisms, and outlook.
        Gastroenterology. 2015; 149: 223-237
        • Petrof E.O.
        • Gloor G.B.
        • Vanner S.J.
        • et al.
        Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.
        Microbiome. 2013; 1: 3
        • McCune V.L.
        • Struthers J.K.
        • Hawkey P.M.
        Faecal transplantation for the treatment of Clostridium difficile infection: a review.
        Int J Antimicrob Agents. 2014; 43: 201-206
        • Bakken J.S.
        • Borody T.
        • Brandt L.J.
        • et al.
        Treating Clostridium difficile infection with fecal microbiota transplantation.
        Clin Gastroenterol Hepatol. 2011; 9 (United States: 2011 AGA Institute. Published by Elsevier Inc): 1044-1049
        • Brandt L.J.
        American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.
        Am J Gastroenterol. 2013; 108: 177-185